Great Oaks Venture Capital is a leading early-stage venture capital firm investing in innovative startups. They partner with founders at the earliest stages, supporting them in building enduring businesses across the United States. Their investments range from $50,000 to $500,000.

Creandum supports early-stage founders in building global, category-defining companies. They commit to hard-working founding teams with global ambition, focusing on product experience and design. Creandum aims to be a trusted partner throughout the company's journey.

Wasabi Ventures Partners allows accredited investors to co-invest alongside Wasabi Ventures in startups. The firm offers access to due diligence materials and allows partners to select investments for their portfolios. A triple vetting process is employed to mitigate risk.

Elaia is a leading European Digital & Deep Tech VC firm. They back ambitious tech entrepreneurs with capital and care, striving for performance with values. Their focus is on early-stage ventures and building tomorrow's European champions.

Icehouse Ventures is an early-stage venture capital firm that invests in brave Kiwi founders building global companies from New Zealand. They've invested over $488m into over 340 New Zealand companies since 2003 and have over $750m in assets under management.

Aperture Venture Partners is a healthcare-focused investment firm committed to working with exceptional entrepreneurs to build innovative companies in the medical device, pharmaceutical, healthcare IT/services and diagnostic sectors. Our partners have deep industry knowledge and a track record of success in helping outstanding companies realize their potential.

Borealis Ventures partners closely with exceptional entrepreneurs to build market-defining companies. Their focus is on transforming healthcare through new therapies, digital innovation, and other technologies. They are lifecycle investors working with syndicate partners to ensure ample resources for their portfolio companies.

Arboretum Ventures is a healthcare venture capital firm based in Ann Arbor, Michigan. They focus on early-stage investments in medical devices, life science tools, tech-enabled care delivery, and pharma adjacencies. Their investment strategy emphasizes under-ventured opportunities and building strong partnerships with entrepreneurs.

Yaletown Partners invests in technology companies at the emerging growth stage, leveraging their expertise to help companies scale. Their focus is on transformative growth and sustainable impact, modernizing traditional industries.

Sopris Venture Capital is a multi-strategy investment firm with a single source of long-term strategic capital. They focus on healthcare and SaaS/tech-enabled businesses, providing early-stage growth capital and acting as strategic advisors to help portfolio companies create value.

Legend Capital is a leading VC&PE investor focusing on early-stage and growth-stage opportunities in China. It manages over US$10 billion in commitments and has invested in around 600 companies across various sectors. The firm emphasizes long-term sustainable investment and incorporates ESG factors into its strategy.

Peregrine Ventures is a leading global life science venture capital fund that invests in and supports life-changing healthcare opportunities. They leverage decades of entrepreneurial experience to build successful companies and provide strategic guidance throughout a company's lifecycle. Peregrine focuses on improving patients' quality of life through innovative medical technologies.